About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

UNKNOWNNCT05686343

Hemodynamically Important Patent Ductus Arteriosus in Newborns Under 32 Weeks

To define the characteristics of hemodynamically significant PDA by echocardiography, to investigate the systemic effects of the ductus with cerebral and renal Doppler flow studies, and to determine t...

Lead sponsor: Ankara University•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Clareo turns complex medical information into clear understanding you can use.

Bring this clarity to your next appointment.

Keep all your medical notes and next steps in one place.

Contacts

Özlem Bayram

CONTACT

05058192105 drbayram.ozlem@gmail.com

Sponsors

Lead Sponsor

Ankara University

Age

0 - 0 years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•Born at less than 32 weeks newborns

Exclusion Criteria

•Congenital heart disease
•Syndromic and/or major congenital anomaly

Related studies

Active Not RecruitingPhase 3

Management of the PDA Trial

NCT03456336 · Infant, Premature, Patent Ductus Arteriosus, and more

COMPLETEDPhase 2/3

Prophylactic IV Paracetamol in Extremely Premature Infants

NCT07067177 · Patent Ductus Arteriosus in Preterm Infants, Patent Ductus Arteriosus After Premature Birth, and more

WITHDRAWNPhase 2

Indomethacin PK-PD in Extremely Preterm Neonates

NCT04025177 · Patent Ductus Arteriosus After Premature Birth

Combined Lung Ultrasounds and Transthoracic Electrical Bioimpedance in Preterm Infants With Respiratory Distress.

NCT04359134 · Respiratory Distress Syndrome in Premature Infant, Patent Ductus Arteriosus After Premature Birth, and more

The Effects of Phototherapy in Preterm Infants Pda

NCT03675425 · Patent Ductus Arteriosus After Premature Birth, Hyper Bilirubinemia

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: January 17, 2023Terms

Trial snapshot

StatusUNKNOWN

Phase—

Enrollment70

Start dateJul 2022

Last updatedJan 17, 2023

Condition

Patent Ductus Arteriosus After Premature Birth

Locations shown

Özlem Bayram

Ankara

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: January 17, 2023Data synced to Clareo: May 3, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions